Literature DB >> 28868479

Skin Metastases: The Visible Face of a Disastrous Unusual Finding.

Sílvia Giestas1, Adriano Casela1, Cláudia Agostinho1, Paulo Souto1, Ernestina Camacho1, M Julião2, Maria Augusta Cipriano2, Carlos Sofia1.   

Abstract

Entities:  

Keywords:  Carcinoma, Acinar Cell; Pancreatic Neoplasms; Skin Neoplasms/secondary

Year:  2016        PMID: 28868479      PMCID: PMC5580018          DOI: 10.1016/j.jpge.2015.12.002

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN: 2387-1954


× No keyword cloud information.

Introduction

Acinar cell carcinoma (ACC) of the pancreas is a rare pancreatic malignancy, constituting only 1–2% of all exocrine pancreatic tumors.1, 2, 3 There is a slight male preponderance and it mostly presents in 5–7th decades of life. ACC arise more commonly from the head of the pancreas. Clinical symptoms are usually non-specific. In contrast to ductal adenocarcinoma, ACC rarely obstructs the common bile duct because it generally compresses and does not infiltrate into adjacent structures, so jaundice is infrequent (12%). It has a unique ability to produce pancreatic enzymes. Paraneoplastic syndrome may be the only presenting symptom in 15% of patients. Lipase hypersecretion syndrome characterized by subcutaneous fat necrosis, polyarthralgia and peripheral eosinophilia is a type of paraneoplastic syndrome associated with it. Skin nodules in this syndrome are commonly seen on the lower extremities and often mistaken for metastatic disease.1, 2, 3 Surgical resection is the best treatment for localized ACC but this is a highly aggressive tumor. Approximately 50% of the cases presented with metastasis at diagnosis. More than 70% the patients who undergo surgical resection are eventually confirmed to show recurrent disease.2, 3 Chemotherapy and radiotherapy are therapeutic options when ACC is unresectable or recurs after resection, but no effective treatment strategies have been established. Although recent studies have clarified the characteristics of ACC it still has not been fully understood.4, 5 We report a rare case of ACC with widespread metastases in a 35-year-old woman who presented with subcutaneous nodules as the initial symptom without evidence of subcutaneous fat necrosis. To our knowledge, this is the second report of ACC with skin metastases.

Clinical case

A 35-year-old woman presents with a one week history of jaundice, abdominal discomfort and intensive asthenia associated with abrupt growth of painful nodules in the neck, abdominal wall and lower right limb. No history of trauma and fever. Without significant previous medical history. She had a delivery eight months ago without complications. Laboratory tests showed cholestasis (gamma glutamyl transpeptidase 346 U/L (<55); alkaline phosphatase 230 U/L (40–150); total bilirubin 4.4 mg/dL (0.3–1.2); direct bilirubin 2.8 mg/dL (0.1–0.5)) without other alterations. Ultrasonography showed moderate dilatation of the main bile duct and could not define the cause of obstruction. Computed tomography revealed multiple metastases in the lymph nodes (the largest with 10 cm, Fig. 1A and B), in the skin/subcutaneous tissue, muscular (Fig. 1C) and also showed a 3 cm mass involving the uncinate process suggestive of neoplastic nature (Fig. 1D). Positron emission tomography confirmed a hypermetabolic mass in the topography of the pancreas (probable primary lesion) and extensive metastasis of the lymph nodes and also in the muscle, lung, bone, cutaneous/subcutaneous tissue and brain (Fig. 2). A biopsy of the cervical node was performed and histological analysis revealed an undifferentiated carcinoma but with immunohistochemistry findings suggestive of ACC of the pancreas (Fig. 3). Under palliative care, patient died tree months after the diagnosis.
Figure 1

Computed tomography: huge cervical lymph node metastasis (A and B); muscle metastasis of lower right limb (C); mass with 3 cm involving the uncinate process suggestive of malignancy (D).

Figure 2

Positron emission tomography confirmed widespread metastases (A) of the lymph nodes (B) and in various other organs including the brain (C), bone (C), muscle (E) and skin/subcutaneous tissue (E).

Figure 3

Histological analysis of the biopsy of the cervical node. Hematoxylin and eosin staining (A): poorly differentiated neoplastic cells with focal acinar formations, large nuclei exhibiting irregular chromatin clumping, size variation, and many mitotic figures are present, consistent with aggressive growth. Immunohistochemical staining (B): neoplastic cells express cytokeratin 8/18, cytokeratin CAM5.2, cytokeratin AE1/AE3, BCL10, β-catenin and alpha 1 antitrypsin.

Computed tomography: huge cervical lymph node metastasis (A and B); muscle metastasis of lower right limb (C); mass with 3 cm involving the uncinate process suggestive of malignancy (D). Positron emission tomography confirmed widespread metastases (A) of the lymph nodes (B) and in various other organs including the brain (C), bone (C), muscle (E) and skin/subcutaneous tissue (E). Histological analysis of the biopsy of the cervical node. Hematoxylin and eosin staining (A): poorly differentiated neoplastic cells with focal acinar formations, large nuclei exhibiting irregular chromatin clumping, size variation, and many mitotic figures are present, consistent with aggressive growth. Immunohistochemical staining (B): neoplastic cells express cytokeratin 8/18, cytokeratin CAM5.2, cytokeratin AE1/AE3, BCL10, β-catenin and alpha 1 antitrypsin. Our patient was an uncommon presentation of a rare tumor with widespread metastases to various organs including the skin. This case emphasizes that ACC diagnosis although rare and usually associated with advanced ages cannot be ruled out in young patients.

Ethical disclosures

Protection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data

The authors declare that no patient data appear in this article.

Right to privacy and informed consent

The authors declare that no patient data appear in this article.

Conflicts of interest

The authors have no conflicts of interest to declare.
  5 in total

1.  Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy.

Authors:  Maeve A Lowery; David S Klimstra; Jinru Shia; Kenneth H Yu; Peter J Allen; Murray F Brennan; Eileen M O'Reilly
Journal:  Oncologist       Date:  2011-10-31

2.  Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases.

Authors:  D S Klimstra; C S Heffess; J E Oertel; J Rosai
Journal:  Am J Surg Pathol       Date:  1992-09       Impact factor: 6.394

3.  A case of pancreatic acinar cell carcinoma metastatic to skin.

Authors:  Minori Ikezoe; Tamao Nishihara; Kazunori Yanagawa; Takashi Kohro; Takuro Yamai; Seriko Ikezoe; Yuichi Yasunaga; Yoshiaki Inui; Masahiro Nishikawa
Journal:  Rare Tumors       Date:  2010-12-31

Review 4.  Acinar Cell Carcinoma of the Pancreas: Overview of Clinicopathologic Features and Insights into the Molecular Pathology.

Authors:  Stefano La Rosa; Fausto Sessa; Carlo Capella
Journal:  Front Med (Lausanne)       Date:  2015-06-15

5.  Acinar cell carcinoma of the pancreas: clinical and cytomorphologic characteristics.

Authors:  Adam D Toll; Ralph H Hruban; Syed Z Ali
Journal:  Korean J Pathol       Date:  2013-04-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.